BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Park H, Yoon JY, Park KH, Kim DY, Ahn SH, Han KH, Chon CY, Park JY. Hepatocellular carcinoma in Budd-Chiari syndrome: A single center experience with long-term follow-up in South Korea. World J Gastroenterol 2012; 18(16): 1946-1952 [PMID: 22563176 DOI: 10.3748/wjg.v18.i16.1946]
URL: https://www.wjgnet.com/1007-9327/full/v18/i16/1946.htm
(0) (0) (5471) (44)
Number Citing Articles
1
Andrea Mancuso. Budd–Chiari Syndrome Management: Controversies and Open Issues. Diagnostics 2022; 12(11) doi: 10.3390/diagnostics12112670
2
Xingshun Qi, Weirong Ren, Yongji Wang, Xiaozhong Guo, Daiming Fan. Survival and prognostic indicators of Budd–Chiari syndrome: a systematic review of 79 studies. Expert Review of Gastroenterology & Hepatology 2015; 9(6) doi: 10.1586/17474124.2015.1024224
3
Dominique-Charles Valla. Budd–Chiari syndrome/hepatic venous outflow tract obstruction. Hepatology International 2018; 12(S1) doi: 10.1007/s12072-017-9810-5
4
Chao Zhang, Yongquan Gu, Ce Bian, Guangchang Zhu, Tao Luo, Chao Yan, Zhonggao Wang. Hybrid Treatment for Budd–Chiari Syndrome: A Case Report by 11-Year Follow-up. Annals of Vascular Surgery 2017; 38 doi: 10.1016/j.avsg.2016.05.132
5
Andrea Mancuso. Focusing the Controversies in Budd-Chiari Syndrome Management. The International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666210406162525
6
Lin-Sun Li, Byung-Boong Lee, Samuel Han, Fei-Yun Wu, Yi Xu, Ducksoo Kim, Jean Paul Colon Pons, Qing-Qiao Zhang, Hai-Bin Shi, Hao Xu, Young H Kim, Naomi Shin. Redefining Budd-Chiari syndrome: A systematic review. World Journal of Hepatology 2016; 8(16): 691-702 doi: 10.4254/wjh.v8.i16.691
7
Kumble Seetharama Madhusudhan, Sanjay Sharma. Ultrasonography in pediatric Budd–Chiari syndrome. Pediatric Radiology 2020; 50(12) doi: 10.1007/s00247-020-04753-7
8
Pierre-Emmanuel Rautou, Lucile Moga, Virginia Hernandez-Gea, Walter Ageno, Sarwa Darwish Murad, Juan-Carlos Garcia-Pagan, Maria Guido, Valérie McLin, Dhiraj Tripathi, Valérie Vilgrain. EASL Clinical Practice Guidelines on vascular diseases of the liver. Journal of Hepatology 2026; 84(2) doi: 10.1016/j.jhep.2025.08.001
9
Marta Martín-Llahí, Agustín Albillos, Rafael Bañares, Annalisa Berzigotti, M. Ángeles García-Criado, Joan Genescà, Virginia Hernández-Gea, Elba Llop-Herrera, Helena Masnou-Ridaura, José Mateo, Carmen A. Navascués, Ángela Puente, Marta Romero-Gutiérrez, Macarena Simón-Talero, Luis Téllez, Fanny Turon, Cándido Villanueva, Roberto Zarrabeitia, Juan Carlos García-Pagán. Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver. Gastroenterología y Hepatología (English Edition) 2017; 40(8) doi: 10.1016/j.gastre.2017.03.014
10
Qiuhe Wang, Guohong Han. Diagnostic Methods for Cirrhosis and Portal Hypertension. 2018;  doi: 10.1007/978-3-319-72628-1_17
11
Yuriko Kusumi, Takumu Hasebe, Manami Hayashi, Yuki Kamikokura, Shin Otake, Hidemi Hayashi, Yu Ota, Shunsuke Nakajima, Kazunobu Aso, Koji Sawada, Mishie Tanino, Mikihiro Fujiya. Hepatocellular Carcinoma Arising Adjacent to Antiphospholipid Syndrome-associated Hepatic Infarction in a Non-cirrhotic Liver. Internal Medicine 2025; 64(19) doi: 10.2169/internalmedicine.5081-24
12
Lucia Giuli, Valeria De Gaetano, Giulia Venturini, Ersilia Arvonio, Marco Murgiano, Antonio Gasbarrini, Francesco Santopaolo, Francesca Romana Ponziani. Role of Vascular Liver Diseases in Hepatocellular Carcinoma Development. Cancers 2025; 17(13) doi: 10.3390/cancers17132060
13
Susana Seijo, Laurie D. DeLeve. Yamada' s Textbook of Gastroenterology. 2015;  doi: 10.1002/9781118512074.ch111
14
Kang-Shuai Li, Sen Guo, Yu-Xin Chen, Zong-Li Zhang. Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1075685
15
Yoshihiro Furuichi, Masayoshi Kage, Masayuki Ohta, Satoko Ohfuji, Hideyuki Sasaki, Hisashi Hidaka, Hiroshi Yoshida, Tatsuya Kanto, Hironori Kusano, Tomohiko Akahoshi, Katsutoshi Obara, Makoto Hashizume, Yukio Kuniyoshi, Takumi Kawaguchi, Hironao Okubo, Tsuyoshi Ishikawa, Masashi Hirooka, Yasuko Iwakiri, Masaki Nio, Atsushi Tanaka. Guidelines for the diagnosis and treatment of idiopathic portal hypertension, extrahepatic portal obstruction, and Budd–Chiari syndrome in Japan. Hepatology Research 2024; 54(11) doi: 10.1111/hepr.14118
16
Anandini Suri, Varun K. Sharma, Prajakta R. Ranade, Shaji Marar, Aabha Nagral. Ruptured hepatocellular carcinoma in a child with Budd-Chiari syndrome. Indian Pediatrics 2016; 53(9) doi: 10.1007/s13312-016-0941-x
17
Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction. Alimentary Pharmacology & Therapeutics 2015; 41(10) doi: 10.1111/apt.13173
18
Laurie D. Deleve, Susana Seijo. Zakim and Boyer's Hepatology. 2018;  doi: 10.1016/B978-0-323-37591-7.00044-6
19
Mohammad Sakr, Sara M. Abdelhakam, Hany Dabbous, Amr Hamed, Zeinab Hefny, Waleed Abdelmoaty, Mohamed Shaker, Mohamed El‐Gharib, Ahmed Eldorry. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd‐Chiari syndrome. Liver International 2017; 37(3) doi: 10.1111/liv.13219
20
Next-Generation Sequencing Identifies Novel Germline Mutations in Patients with Budd–Chiari Syndrome-Associated Hepatocellular Carcinoma. Digestive Diseases and Sciences 2025; 70(5) doi: 10.1007/s10620-025-08942-y
21
Dominique-Charles Valla. Portal Hypertension VI. 2016;  doi: 10.1007/978-3-319-23018-4_39
22
Lamia Y.K. Haque, Joseph K. Lim. Budd-Chiari Syndrome. Clinics in Liver Disease 2020; 24(3) doi: 10.1016/j.cld.2020.04.012
23
Diagnosis and treatment guidelines for aberrant portal hemodynamics. Hepatology Research 2017; 47(5) doi: 10.1111/hepr.12862
24
Marta Martín-Llahí, Agustín Albillos, Rafael Bañares, Annalisa Berzigotti, M. Ángeles García-Criado, Joan Genescà, Virginia Hernández-Gea, Elba Llop-Herrera, Helena Masnou-Ridaura, José Mateo, Carmen A. Navascués, Ángela Puente, Marta Romero-Gutiérrez, Macarena Simón-Talero, Luis Téllez, Fanny Turon, Cándido Villanueva, Roberto Zarrabeitia, Juan Carlos García-Pagán. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017; 40(8) doi: 10.1016/j.gastrohep.2017.03.011
25
Iván A. González, Dhanpat Jain. Diagnosis and classification of vascular liver disorders. Diagnostic Histopathology 2023; 29(1) doi: 10.1016/j.mpdhp.2022.10.005
26
Jian-Ping Dou, Jie Yu, Zhi-yu Han, Fang-yi Liu, Zhi-gang Cheng, Ping Liang. Microwave ablation for hepatocellular carcinoma associated with Budd–Chiari syndrome after transarterial chemoembolization: an analysis of ten cases. Abdominal Radiology 2017; 42(3) doi: 10.1007/s00261-016-0923-4
27
Ya-dong Wang, Huan-zhou Xue, Xiao Zhang, Zong-quan Xu, Qing-feng Jiang, Quan Shen, Miao Yu, Ke Li, Meng Jia. Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma. Chinese Medical Journal 2013; 126(19) doi: 10.3760/cma.j.issn.0366-6999.20130898
28
Akash Shukla, Ananta Shreshtha, Amar Mukund, Chhagan Bihari, C. E. Eapen, Guohong Han, Hemant Deshmukh, Ian Homer Y. Cua, Cosmas Rinaldi Adithya Lesmana, Mamun Al Meshtab, Masayoshi Kage, Roongruedee Chaiteeraki, Sombat Treeprasertsuk, Suprabhat Giri, Sundeep Punamiya, Valerie Paradis, Xingshun Qi, Yasuhiko Sugawara, Zaigham Abbas, Shiv Kumar Sarin. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatology International 2021; 15(3) doi: 10.1007/s12072-021-10189-4
29
Shalimar, Akash Shukla, Subrat Kumar Acharya, Shashi Bala Paul, Shivanand Gamanagatti, Ashwani Kumar Mishra, Ramesh Kumar, Ravi Mohanka, Amit Gupte, Arun Vaidya, Anshuman Elhence, Gautam Jain, Ayush Agarwal, Arnav Aggarwal, Shekhar Swaroop, Sagnik Biswas, Ankit Agarwal. Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome. World Journal of Gastrointestinal Oncology 2024; 16(3): 699-715 doi: 10.4251/wjgo.v16.i3.699
30
Lionel Arrivé, Jessica Zucman‐Rossi, Pierre Balladur, Dominique Wendum. Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis. Hepatology 2016; 64(2) doi: 10.1002/hep.28590
31
Nawel Afredj, Nabil Debzi. Budd-Chiari Syndrome. 2020;  doi: 10.1007/978-981-32-9232-1_9
32
Alisha Chaubal, Akash Shukla. Budd-Chiari Syndrome. 2020;  doi: 10.1007/978-981-32-9232-1_18
33
Juan Putra, Linda D. Ferrell, Annette S.H. Gouw, Valerie Paradis, Arvind Rishi, Christine Sempoux, Charles Balabaud, Swan N. Thung, Paulette Bioulac-Sage. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon. Modern Pathology 2020; 33(4) doi: 10.1038/s41379-019-0374-x
34
Sheng-Yan Liu, Lu-Hao Li, Zhao-Chen Liu, Su-Xin Li, Xiao-Wei Dang. Development of a prognostic scoring system for hepatic vena cava Budd-Chiari syndrome with hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2024; 23(4) doi: 10.1016/j.hbpd.2023.03.005
35
Andrea Mancuso. Budd-Chiari Syndrome. 2020;  doi: 10.1007/978-981-32-9232-1_19
36
Debi Prasad, Mindie H. Nguyen. Epidemiology, pathogenesis, diagnosis, surveillance, and management of hepatocellular carcinoma associated with vascular liver disease. The Kaohsiung Journal of Medical Sciences 2021; 37(5) doi: 10.1002/kjm2.12368
37
Divyanshi Sharma, Sanjeev Khera, Ganesh Saravagi, Pawan Kumar Dhaman. Hepatocellular carcinoma as a complication of chronic Budd-Chiari syndrome (BCS) in a child. BMJ Case Reports 2024; 17(8) doi: 10.1136/bcr-2024-261764
38
Dominique‐Charles Valla. Schiff's Diseases of the Liver. 2017;  doi: 10.1002/9781119251316.ch33
39
Xixiang Gao, Zhu Tong, Lianrui Guo, Jianxin Li, Jian Zhang, Yongquan Gu. Angioplasty for Budd-Chiari Syndrome in a Child with 26-Year Follow-up. Annals of Vascular Surgery 2018; 51 doi: 10.1016/j.avsg.2018.03.004
40
Qianxin Huang, Qingqiao Zhang, Hao Xu, Maoheng Zu, Yuming Gu, He Ma, Wei Kang, Caifang Ni. Clinical characteristics and risk factors of hepatocellular carcinoma development in Budd-Chiari syndrome patients after endovascular treatment. Digestive and Liver Disease 2025; 57(6) doi: 10.1016/j.dld.2025.02.008
41
Laure Elkrief, Dominique Valla. Evidence‐based Gastroenterology and Hepatology 4e. 2019;  doi: 10.1002/9781119211419.ch42
42
Faisal Khan, Matthew J. Armstrong, Homoyon Mehrzad, Frederick Chen, Desley Neil, Rachel Brown, Owen Cain, Dhiraj Tripathi. Review article: a multidisciplinary approach to the diagnosis and management of Budd‐Chiari syndrome. Alimentary Pharmacology & Therapeutics 2019; 49(7) doi: 10.1111/apt.15149
43
Qiuhe Wang, Guohong Han. Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future. Abdominal Radiology 2018; 43(8) doi: 10.1007/s00261-017-1341-y
44
Satoko Ohfuji, Yoshihiro Furuichi, Tomohiko Akahoshi, Masayoshi Kage, Katsutoshi Obara, Makoto Hashizume, Tomoka Matsuura, Wakaba Fukushima, Yosikazu Nakamura. Japanese periodical nationwide epidemiologic survey of aberrant portal hemodynamics. Hepatology Research 2019; 49(8) doi: 10.1111/hepr.13343
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.